KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Operating Leases (2019 - 2026)

Twist Bioscience has reported Operating Leases over the past 8 years, most recently at $85.4 million for Q1 2026.

  • Quarterly Operating Leases rose 31.22% to $85.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $85.4 million through Mar 2026, up 31.22% year-over-year, with the annual reading at $61.8 million for FY2025, 12.06% down from the prior year.
  • Operating Leases was $85.4 million for Q1 2026 at Twist Bioscience, roughly flat from $85.8 million in the prior quarter.
  • Over five years, Operating Leases peaked at $94.0 million in Q4 2022 and troughed at $61.8 million in Q3 2025.
  • The 5-year median for Operating Leases is $79.2 million (2023), against an average of $78.6 million.
  • Year-over-year, Operating Leases soared 194.44% in 2022 and then decreased 28.14% in 2025.
  • A 5-year view of Operating Leases shows it stood at $94.0 million in 2022, then dropped by 2.23% to $91.9 million in 2023, then fell by 26.44% to $67.6 million in 2024, then grew by 26.96% to $85.8 million in 2025, then decreased by 0.48% to $85.4 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Operating Leases are $85.4 million (Q1 2026), $85.8 million (Q4 2025), and $61.8 million (Q3 2025).